New fund Alis offers struggling biotechs an off-ramp: Finance Report

Two biotech veterans have set up a new fund to give troubled biotechs a way to return cash to shareholders as they evaluate options such as selling, merging or winding down.

Led by former biopharma R&D executive Annalisa Jenkins and banker Nicholas Johnston, London-based Alis Biosciences Ltd. will offer a series of capital structures to struggling companies that have weathered setbacks in the clinic, with regulators, or in the marketplace, and are facing uncertain futures...